You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥師幫用户覆蓋進一步提速,1-4月基層醫療機構用户數新增超40,000家
格隆匯 05-07 10:59
藥師幫5月6日發佈官方信息稱,2024年1-4月新增基層醫療機構用户數超40,000家。據瞭解,近兩年來藥師幫持續加速引入基層醫療機構用户:2022年,公司共計新增基層醫療機構用户約30,000家;2023年,公司共計新增基層醫療機構用户超70,000家。截至2023年12月31日,藥師幫已覆蓋基層醫療機構約246,000家。今年以來,藥師幫重點開拓覆蓋基層醫療機構,提高對其的滲透率,同時加速引入針劑、中藥等特色需求品類,通過超級診所日、中藥超級單品日等活動提升其品種滿足率,此外,針對廣大的基層醫療機構市場,藥師幫持續推進光譜雲診服務,依託醫療大數據追蹤分析,實現了小程序報到、問診開方、患者管理、系統管理等功能,滿足醫生獨立坐診類型客户的需要,幫助提升基層醫療機構的信息管理效率。根據弗若斯特沙利文的資料,截至2021年末,中國有約977,790家基層醫療機構,未來仍將維持穩定增長態勢,預計自2020年起以1.3%的年複合增長率增至2026年的約1,064,000家。公開資料顯示,今年4月藥師幫分別以每股8.21港元、每股7.98港元、每股8.10港元的價格,於市場上回購合共30萬股股份,總代價為242.9萬港元。截至目前,公司已累計進行6次回購,合計回購57萬股,累計回購金額772.4萬港元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account